SPDR S&P Health

Multiple Institutional Investors Disclose Increased Stakes in UnitedHealth Group on May 19, 2026

Wells Fargo Raises UnitedHealth Group's Price Target to $397

DaVita Sets 2030 ESG Goals: Focusing on Patient Transplants, Workforce Development, and 100% Renewable Energy

Judge grants Luigi Mangione's request to suppress evidence in UnitedHealth CEO murder case

UnitedHealth Group will hold its Annual General Meeting on June 2, 2026

Berkshire Hathaway exited its entire position in UnitedHealth Group during the first quarter, causing the stock to slide 4% overnight.

UnitedHealthcare's D.C. Community Plan Earns NCQA Distinction for Long-Term Services and Supports

UnitedHealth's Optum Rx Introduces New Pharmacy Care Model for Transparency

UnitedHealth Group to Host UHC Medicare Sales Virtual Job Fair

Canada Post Corp Registered Pension Plan Increases Stake in UnitedHealth Group

UnitedHealth Group Outlines Plan to Cut Medicare Advantage Members to Protect Profitability

UnitedHealth Group Expects to Complete at Least $2 Billion in Share Repurchases by End of Q2

Leuthold Group LLC acquired a new $9.29 million stake in UnitedHealth Group.

UnitedHealth's 2026 Health Trends Report projects an 8.5% increase in medical costs.

Qsemble Capital Management LP Makes New $3.42 Million Investment in UnitedHealth Group

Stephens Inc. AR Purchases 9,617 Shares of UnitedHealth Group

Regulatory framework for Pharmacy Benefit Managers (PBMs) may impact UnitedHealth's OptumRx division

Analysts Give UnitedHealth an Average Rating of "Moderate Buy" with a Price Target of $378.88

Management States Optum Health's Margin Recovery is Ahead of Schedule at Recent Conference

UnitedHealth Group accelerates AI strategy, with AI investment reaching $1.5 billion within the year

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Wellgistics Health

Huachen AI Parking Management Tech

GeoVax Labs

Sunshine Biopharma

AIM ImmunoTech

Virax Biolabs

NextNRG

GCT Semiconductor

UNHG

GSA Capital Partners LLP increased its stake in UnitedHealth Group (NYSE:UNH) by 203.2% in Q4, owning 6,673 shares valued at $2.2 million. Other institutional investors also raised their holdings. Analysts have upgraded their ratings, with Barclays setting a price target of $373.00. Despite Berkshire Hathaway's exit affecting sentiment, UnitedHealth's recent earnings showed positive results, maintaining a market cap of $354.57 billion.

Market Beat

Unitedhealth

Health Care Select Sector SPDR

iShares US Healthcare Providers

VG Health

Leverage Shares 2X Long UNH Daily ETF

iShares Global Healthcare

Barclays

Jefferies Financial

KeyCorp

Berkshire Hathaway

Berkshire Hathaway B

Thomson Reuters

KEYCORP DEP SHS REP 1/40TH NON CUM PER PFD SER G

KEYCORP DEP SHS REPSTG 1/40TH INT PERP NON CUM H

KEYCORP DEP SHS REP 1/40TH PERP PFD SER F USD25

KEYCORP DEP SHS REP 1/40TH NON CUM PFD SER E

UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP

Handelsbanken Fonder AB increased its stake in HCA Healthcare, Inc. by 7.9% in Q4, owning 213,272 shares valued at approximately $99.57 million. Other hedge funds also adjusted their positions. HCA's stock opened at $422.60, with a market cap of $93.75 billion. The company reported Q1 earnings of $7.15 per share, slightly below estimates, and announced a quarterly dividend of $0.78. Analysts have varied price targets, with UBS raising theirs to $635.00.

HCA Healthcare

UBS Group AG

Goldman Sachs

Toronto Dominion Bank

ROYAL BANK OF CANADA

GS Hldg R

Handelsbanken Fonder AB Boosts Position in HCA Healthcare, Inc. $HCA

BRK.B

BRK.A

Berkshire Hathaway sold its entire stake in UnitedHealth in Q1 2026, leading to a decline in the insurer's stock. CEO Greg Abel's strategy reflects a shift towards quicker trades, contrasting with Warren Buffett's long-term approach. Despite the sell-off, UnitedHealth is exceeding earnings forecasts and focusing on AI investments and cost controls to enhance profitability.

- Berkshire Hathaway divested its entire UnitedHealth position in Q1 2026, leading to a decline in the insurer's stock.  
- CEO Greg Abel is adopting a strategy of quicker trades and capital redeployment, contrasting with Warren Buffett's long-term investment approach.  
- Despite the sell-off, UnitedHealth is exceeding earnings forecasts and focusing on AI investments and cost controls to enhance profitability.

Berkshire's UnitedHealth exit sends shares lower despite turnaround

AMST

Amesite Inc. (NASDAQ:AMST) shares surged 90.82% to $1.50 in after-hours trading following the announcement of its largest enterprise deployment and a 171% year-over-year revenue growth to $83,330. The company secured a new customer for its AI-native NurseMagic platform, aimed at enhancing patient documentation efficiency. Despite this, AMST has seen a 74.06% decline over the past year and closed the regular session at $0.79, down 4.58%. The stock currently trades near its 52-week low.

benzinga_article

Amesite

Taiwan Semiconductor

NVIDIA

Tesla

NVIDIA Corporation

Amesite (AMST) Stock Is Trending Overnight — Here's Why It Moved Nearly 91% In After-Hours Session

HIMS

HIMY

HIMZ

Hims & Hers Health raises $350 million through convertible notes, aimed at supporting global expansion and accelerating AI-driven platform development.

Unusual Whales

Hims & Hers Health

Defiance Leveraged Long +Income HIMS ETF

Defiance Daily Target 2X Long HIMS ETF

Hims & Hers Health raises $350 million through convertible notes, aimed at supporting global expansion and accelerating AI-driven platform development.

ResMed Inc. (RMD) shares rose 1.12% to $204.15 on Monday, outperforming a mixed stock market session. The Dow Jones increased by 0.32%, while the S&P 500 fell by 0.07%. ResMed's stock remains 30.52% below its 52-week high of $293.81, reached on August 22nd. Trading volume was 1.0 million, below the 50-day average of 1.2 million.

MarketWatch Automated

Resmed

iShares US Medical Devices

SPDR S&P Health Equip

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

Dow Jones Industrial Average

S&P 500

Factset Research

ResMed Inc. Stock Rises Monday, Outperforms Market

Amesite Inc. reported Q3 2026 revenue of $83.33K, a net loss of $678.06K, and diluted EPS of ($0.15), compared to $30.69K revenue and ($0.16) EPS in Q3 2025. Revenue growth for the nine months reached $285.7K, driven by a shift to healthcare markets and the launch of AI-driven NurseMagic™. The company focused on operational efficiency, reducing spending and shifting to monthly service contracts.

TradingView

Amesite Inc. 3Q 2026: Revenue $83.33K, EPS ($0.15) — 10-Q Summary

PNTG

Pennant Group to Participate in the 2026 RBC Global Healthcare Conference | PNTG Stock News

StockTitan

Pennant

Pennant Group to Participate in the 2026 RBC Global Healthcare Conference | PNTG Stock News

The health insurer's shares fell early Monday after Berkshire disclosed it exited its position in the company in the first quarter.

UnitedHealth drop proves Berkshire’s market power post-Buffett

UnitedHealth Group Inc. (NYSE:UNH) shares fell 3.05% in premarket trading after Berkshire Hathaway disclosed it sold its entire stake of about 5 million shares. This divestment comes as UnitedHealth expands its AI initiatives, monitoring employee usage of AI tools and investing $1.5 billion in AI this year. Despite the stock drop, UnitedHealth reported strong Q1 earnings, with adjusted earnings of $7.23, surpassing estimates. The company has seen an 18% increase in stock value over the past month.

Why Is UnitedHealth Stock Trading Lower On Monday?

SPDR S&P Health(XHS.US)

UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP

Handelsbanken Fonder AB Boosts Position in HCA Healthcare, Inc. $HCA

Berkshire's UnitedHealth exit sends shares lower despite turnaround

Amesite (AMST) Stock Is Trending Overnight — Here's Why It Moved Nearly 91% In After-Hours Session

Hims & Hers Health raises $350 million through convertible notes, aimed at supporting global expansion and accelerating AI-driven platform development.